Breakthrough cubosome technology enhances bioavailability of curcumin and berberine, offering precise pancreatic beta-cell targeting and improved glycemic control in preclinical trials, challenging tr...
WHO’s 2023 report recognizes turmeric for insulin resistance, while clinical studies validate ginger’s blood pressure benefits. Pharmaceutical innovations address bioavailability challenge...
New ADA guidelines and wearable tech integrations are revolutionizing resistance training’s role in glucose control and sarcopenia prevention for 96 million US prediabetic adults. 2023 ADA stand...
Emerging research highlights intermittent fasting’s paradoxical effects – improved metabolic markers versus increased cardiovascular mortality risks, prompting calls for personalized appro...
Recent studies reveal curcumin’s efficacy in reducing blood glucose and improving cardiovascular health, supported by enhanced bioavailability formulations and updated regulatory guidelines for ...
New research shows combined GADA, ICA, and IAA testing identifies 10% of type 2 diabetes cases as LADA, with significant treatment implications. Groundbreaking studies reveal that comprehensive autoan...
Exploring the synergistic effects of cinnamon, fenugreek, and nigella sativa in metabolic management with evidence-based dosing and interaction precautions. Recent clinical studies validate the metabo...
Recent studies reveal konjac’s glucomannan fiber significantly reduces glucose spikes and LDL cholesterol while acting as a potent prebiotic, with safety considerations for different consumption...
New research reveals konjac glucomannan’s frozen gel form significantly boosts SCFA production and gut microbiota diversity in obese mice, offering promising implications for human diabetes mana...
Recent studies confirm intermittent fasting benefits for diabetes and hypertension, while new research highlights emerging protocols and cautions for specific populations. Emerging research demonstrat...
